ALNYLAM PHARMACEUTICALS, INC.;ALNYLAM PHARMACEUTICALS; INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
发明人:
BRIAN BETTENCOURT,KEVIN FITZGERALD,WILLIAM QUERBES,MAKIKO YASUDA,ROBERT DESNICK J.
申请号：
PT13721433
公开号：
PT2836595T
申请日:
2013.04.10
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
